SUMMARY Out of 12 patients in whom phenylephrine terminated ventricular tachycardia, four were selected for detailed studies of its mechanism of action. Pretreatment with edrophonium (15-20 mg, i.v.) decreased, while atropine (2.4 mg, i.v.) increased by at least a factor of two, the dose of phenylephrine required to break ventricular tachycardia. Carotid sinus massage VENTRICULAR TACHYCARDIA (VT) is believed to be unresponsive to enhanced vagal traffic, while supraventricular tachycardias are slowed or converted to normal rhythm.' This time-honored method of clinical differentiation of supraventricular tachycardia with aberrant conduction and VT has become the subject of renewed interest.4 Recently, we reported that phenylephrine terminated six cases of ventricular tachycardia (VT).8 A considerable amount of attention was directed at trying to relate those terminations to a vagal mechanism, but we could not make a firm conclusion on the evidence we had. Since that report, we have examined 12 cases of VT which could be terminated by phenylephrine. Our observations in four of these cases aimed at elucidating the mechanism of phenylephrine's action are detailed in this report.
VENTRICULAR TACHYCARDIA (VT) is believed to be unresponsive to enhanced vagal traffic, while supraventricular tachycardias are slowed or converted to normal rhythm.' This time-honored method of clinical differentiation of supraventricular tachycardia with aberrant conduction and VT has become the subject of renewed interest. 4 Recently, we reported that phenylephrine terminated six cases of ventricular tachycardia (VT).8 A considerable amount of attention was directed at trying to relate those terminations to a vagal mechanism, but we could not make a firm conclusion on the evidence we had. Since that report, we have examined 12 cases of VT which could be terminated by phenylephrine. Our observations in four of these cases aimed at elucidating the mechanism of phenylephrine's action are detailed in this report.
Materials and Methods
Thirteen patients with VT were selected for challenge with phenylephrine based on the following criteria: 1) The VT was recurrent over five or more years. 2) The VT did not occur as a result of or in the presence of acute myocardial ischemia, acute myocardial infarction or severe left ventricular dysfunction of any etiology.
3) The VT produced minimal or no discernible adverse hemodynamic effects. 4) Pressor challenges with phenylephrine were deemed to be safe. In 12 of these 13 patients, phenylephrine terminated VT and among these, four were selected for very detailed examination of a possible vagal role in these terminations. The sole reason for selecting these four particular cases is that they had had numerous episodes of stable VT. In any one case comparisons could be made with either multiple spontaneously occurring episodes of VT or episodes induced by exercise, rapid right atrial or ventricular pacing or timed premature ventricular beats. Intracardiac electrograms were recorded by standard techniques and recorded on an Electronics for Medicine DR-12 recorder. Intracardiac stimulation was performed by means of a Grass S-88 stimulator coupled through stimulus isolation units. The drugs used in these studies included edrophonium hydrochloride (10- following pretreatment with edrophonium in unusually high (15-20 mg, i.v.) doses broke ventricular tachycardia in all four patients. The evidence presented supports the assumption that a vagal mechanism caused both instances of termination. These findings significantly alter our interpretation of vagal interventions in the bedside clinical diagnosis of wide QRS complex tachycardias.
The protocol for study was as follows:
A) The precise dose of phenylephrine needed to break two consecutive episodes of VT was determined. This was done by intravenous bolus injections of phenylephrine starting at a dose of 0.1 mg and increasing this in steps of 0.1-0.2 mg. The blood pressure was carefully monitored either continuously through an intra-arterial line or by repeated cuff determinations. An interval of at least five minutes following the return of the blood pressure to control was allowed to elapse between successive challenges. B) During a third episode of VT, carotid sinus massage (CSM) was applied before and after pretreatment with 10, 15 or 20 mg edrophonium HCI. In instances where edrophonium was administered, right or left sided carotid sinus massage (CSM) was applied as soon as the patient felt some of the muscarinic side effects" (about 30-40 seconds later).
C) During a fourth episode of VT (at least 30 min following step B), the patients were pretreated with a second dose of edrophonium identical to that which permitted VT termination in conjunction with CSM. The dose of phenylephrine needed to terminate VT was now redetermined by bolus injections similar to those used in (A). D) During a fifth episode of VT (at least 30 minutes following step C), the patients were pretreated with atropine 2.4 mg, i.v. Conversion of VT with phenylephrine was now attempted using bolus injections starting at a dose of 0.5 mg and increasing this in steps of 0.2 mg. The maximum challenging dose was limited by not allowing the peak systolic pressure to exceed 200 mm Hg.
The nature and purpose of these studies was fully explained and informed verbal and written consent was obtained from each patient.
Results

Criteria for Ventricular Tachyeardia
In all cases the diagnosis of VT was established by the following criteria:'0 1) The QRS complexes during the tachycardia were 120 msec or greater in duration and totally different from the complexes during supraventricular rhythm (figs. 1-9). 2) Atrioventricular (A-V) dissociation (figs. 1-3, 6, 8) or V-A block ( fig. 7) Inasmuch as both phenylephrine and CSM share vagotonic and sympatholytic properties, the relative importance of the two effects in the termination of VT remains unresolved by our observations. It appears, however, that the two mechanisms may in fact be additive in the sense that an increase in the intensity of either may dampen the requirement for the other and it remains to be determined whether a strong enough pure vagal stimulus will by itself break VT at any level of sympathetic tone. A similar electrophysiologic interplay between vagal and sympathetic influences has recently been shown by Kolman et al. '9 Using intact dogs, they showed that vagal stimulation could restore to normal the ventricular fibrillatory threshold which had been lowered by prior sympathetic nerve stimulation.
There is mounting evidence from different sources which suggests that the vagus nerve may modulate the electrical properties of ventricular tissues. Dressel and Sutter20 have shown that stimulation of the distal cut vagus nerve in dogs can abolish premature ventricular beats which are induced by cyclopropane-epinephrine mixtures. Bailey et al. 2 ' demonstrated that automaticity in His bundle and proximal bundle branch cells is depressed by acetylcholine. Spear and Moore22 have shown that the ventricular pacemaker rate in experimentally induced heart block may be reduced by vagal stimulation. Kent et al. 5 have shown that cholinergic influences raise the ventricular fibrillation threshold in dogs with experimental myocardial infarction while anticholinergic interventions reduce ventricular fibrillation threshold.
In addition, since several groups of investigators have identified histologically the presence of vagal nerve fibers within the ventricular septum of dogs, cats and man,23-25 it is conceivable that any vagally sensitive VT process may involve this region in a crucial way.
It is not possible from our limited experience to date to speculate how frequently or what type of VT is likely to terminate with the maneuvers herein described. The constraints imposed by our selection criteria limited our observations to what may be a homogeneous group of "idiopathic" recurrent VT. Because of the acute rises in blood pressure which result from phenylephrine administration, this form of testing or treatment will have to be used with great discretion in the more common cases of VT which occur in the settings of coronary artery disease or left ventricular dysfunction of diverse causes. It is of interest that all four cases of VT were easily started by exercise and the maneuvers successfully used to convert VT in these patients would tend to counter the autonomic effects of exercise. It is thus possible that the relative balance between vagotonic and sympatholytic requirements for conversion of a given VT may parallel the balance between vagolytic and sympathetic influences incurred during its induction. This possible relationship requires further investigation.
Termination of VT by vagal maneuvers has not to date been a clinically recognized entity. In view of the frequency with which vagal maneuvers are used in the clinical diagnosis of tachyarrhythmias, the elusiveness of the described findings is notable. This could be explained in two ways. First, since it is widely accepted that a wide QRS com- LVH, the standard ECG gave a correlation with LVM of r = 46% and a standard error of estimate of 98 g. The corresponding figures for the MDECG were r = 81% and the root mean square prediction error = 64 g. These results confirm other studies showing that the conventional ECG is of only marginal value in the task of diagnosing LVH in the presence of RBBB. In contrast, the MDECG performs well both in this task and that of quantitating LVH. The results provide further support of the accuracy of the model of the cardiac electrical generator and volume conductor used in the MDECG method.
series of 113 patients with normal conduction has proved that the prediction has a root mean square error of 66 g in such patients.3
The effectiveness of an ECG technique for determining the presence or absence of some particular cardiac condition, or combination of conditions, may be studied by trials on a series of patients. This series must be composed of patients for whom the presence or absence of the conditions is independently and reliably known. Only then can the accuracy of the ECG predictions be assessed.
The present paper reports results on a series of patients with right bundle branch block (RBBB) and compares the ability of the standard 12-lead ECG and the MDECG to detect and quantitate LVH in this situation. In addition, this study provides further validation of the modeling assumptions used in the MDECG method. The non-ECG method used to determine the presence and degree of LVH was quantitative biplane angiography.2
Materials and Methods
To date, 126-lead ECG data have been recorded on 1,234 patients and normal subjects, as part of the MDECG
